Langerhans Cell Histiocytosis (LCH) in Egyptian Children: Does Reactivation Affect the Outcome?

about

Langerhans Cell Histiocytosis (LCH) in Egyptian Children: Does Reactivation Affect the Outcome?

Item

http://www.wikidata.org/entity/Q39443321

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Langerhans Cell Histiocytosis ...... activation Affect the Outcome?

@en

Langerhans Cell Histiocytosis

@nl

type

Item

label

Langerhans Cell Histiocytosis ...... activation Affect the Outcome?

@en

Langerhans Cell Histiocytosis

@nl

prefLabel

Langerhans Cell Histiocytosis ...... activation Affect the Outcome?

@en

Langerhans Cell Histiocytosis

@nl

P1476

Langerhans Cell Histiocytosis ...... activation Affect the Outcome?

@en

P2093

Emad Moussa

http://www.w3.org/2001/XMLSchema#string

Hala Taha

http://www.w3.org/2001/XMLSchema#string

Hany Abdel Rahman

http://www.w3.org/2001/XMLSchema#string

Omayma Hassanein

http://www.w3.org/2001/XMLSchema#string

Tarek Raafat

http://www.w3.org/2001/XMLSchema#string

P2860

Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study.

Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.

Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years

Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.

Medical management of langerhans cell histiocytosis from diagnosis to treatment.

2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients.

Current therapy for Langerhans cell histiocytosis.

Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.

Clinical features and treatment outcomes of Langerhans cell histiocytosis: a nationwide survey from Korea histiocytosis working party.

P2888

s12098-015-1801-8

P304

214-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12098-015-1801-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mohamed Sedky

P577

2015-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279730893

http://www.w3.org/2001/XMLSchema#string

P698

26133729

http://www.w3.org/2001/XMLSchema#string